期刊文献+

宫颈鳞状细胞癌组织中PTEN、PCNA的表达及意义 被引量:2

Expression and significance of PTEN and PCNA in cervical squamous carcinoma tissue
下载PDF
导出
摘要 目的检测酪氨酸磷酸酶蛋白(PTEN)、增殖细胞核抗原(PCNA)的表达并探讨其意义。方法采用免疫组化S-P法检测70例宫颈鳞状细胞癌组织中PTEN、PCNA表达水平,并以11例正常宫颈组织为对照。结果与正常宫颈组织相比,宫颈鳞状细胞癌PTEN的阳性表达率明显降低,而PCNA阳性表达率明显增高(P均<0.05)。PTEN的表达与PCNA的表达呈负相关(r=-0.574,P<0.01)。PTEN、PCNA阳性表达率与宫颈鳞癌组织学分级、临床分期和淋巴结转移有相关性(P均<0.05)。结论PCNA的异常高表达与PTEN的异常低表达参与了宫颈癌的发生、发展过程。联合检测PTEN、PCNA蛋白对宫颈鳞癌临床诊断、确定治疗方案及预后评估有一定意义。 Objective To detect the expression and the significance of PTEN and PCNA in cervical squamous carcinoma. Methods PTEN and PCNA expression were detected by immunohistochemistry method in 70 cases of cervical squamous carcinoma and 11 cases of normal cervical specimens. Results Compared with normal cervical tissue, the positive expression rate of PTEN increased and PCNA reduced in cerrical squamous carcinoma. The expression of PTEN and PCNA was negatively related (r=-0.574, P〈0.01). There were significant correlation between the expression of PTEN, PCNA and the histological grade, clinical stage, lymph node metastasis of cervical squamous carcinoma. Conclusion The abnormal high expression of PCNA and low expression of PTEN participate the pathogenesis of cervical carcinoma. PTEN and PCNA protein can be used in clinical diagnose , treatment and prognosis evaluate of cervical squamous carcinoma.
出处 《山东医药》 CAS 北大核心 2008年第43期17-18,共2页 Shandong Medical Journal
关键词 宫颈肿瘤 宫颈鳞状细胞癌 酪氨酸磷酸酶蛋白 增殖细胞核抗原 免疫组织化学 cervical neoplasms cervical squamous carcinoma phosphatase and tensin homolog proliferating cell nuclear antigen immunohistocbemistry
  • 相关文献

参考文献7

  • 1Harima Y, Sawada S, Nagata K, et al. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy[J]. Int J Oncol, 2001,18 (20) : 493-498.
  • 2Maehama T, Dixon JE. PTEN : a tumor suppressor that functions as a phospholipids phosphatase [ J ].Trends Cell Biol, 1999,9 ( 4 ) : 125-128.
  • 3Besson A, Robbins SM, Yong VM. PTEN in signal transduction and tumorigenesis[J]. Eur J Biochem,1999, 263 (3) : 605-611.
  • 4Hwang PH, Yi HK, Kim DS, et al. Suppresion of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene[ J]. Cancer Lett, 2001,172 ( 1 ) :83-91.
  • 5Frisk T, Foukakis T, Dwinght T. et al, Silencing of the PTEN tumorsuppressor gene in anaplastic thyroid cancerGen[ J]. Chromosomes Cancer, 2003, 35( 1 ) :74-80.
  • 6Korkolopoulou P ,Christodoulou P ,Lekka-katsouli I, et al. Progontic significance of proliferating cell nuclearantigen (PCNA) expression in gliomas[J]. Histopathology , 1994, (25) :349.
  • 7Taftachi R, Ayhan A, Ekici S, et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki267 [ J]. BJU Int, 2005, 95 (4) : 650-654.

同被引文献20

  • 1郭君红,邹丽.RECK基因与基质金属蛋白酶-2相关性在早孕滋养细胞侵袭调控中的作用[J].实用医学杂志,2007,23(5):639-641. 被引量:5
  • 2Czyzewska J,Guzin ska-Ustymowicz K,Pryczynicz A,et al. Immunohistochemical evalualion of Ki-67,PCNA and MCM2 proteins proliferation index(PI)in advanced gastric cancer[J]. Folia Histochem Cytobiol,2009, 47( 2 ) : 289-296.
  • 3Uchikado Y,Natsugoe S,Okumura H,et al. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squarnous cell carcinoma[J]. Clin Cancer Res, 2005,11 (3) : 1174-1180.
  • 4Ebelt, Neid M,Tannapfel A,et al. Prognostic significance of proliferation markers in hepatocellular carcinoma( HCC )[J]. Zentralbl Chit, 2000,125: 597-601.
  • 5Simionescu C,Georgescu CV,Margaritescu C,et al. P53 and PCNA immunoexpression in endometrial carcinomas[J]. Rom J Morphol Embryol, 2006,47(2): 137-141.
  • 6Hebbard LW, Garlatti M, Young LJ, et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model[J]. Cancer Res, 2008,68( 5 ) : 1407-1416.
  • 7Balaram P, Alex S, Panikkar B, et al. Adhesion-related proteins E-cadherin,P-cadherin, CD44,and CD44v6,and antimetastatic protein nm 23H1 in complete hydatidiform moles in relation to invasion potential[J]. Int J Gynecol Cancer, 2004,14(3 ) : 532-539.
  • 8Baranwal S,Alabari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer[J]. Biochem Biophys Res Commun,2009,384 (1):6-11.
  • 9Yuan W, Chen Z,Wu S,et al. Expression of EphA2 and E-cadherin in gastric cancer:correlated with tumor progression and lymphogenous metastasis[J]. Pathol Oncol Res, 2009, 15(3 ) :473-475.
  • 10Xue WC, Feng HC,Tsao SW,et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases[J]. Int J Gvnecol Cancer, 2003,13 (6) : 879-888.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部